Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 141

Similar articles for PubMed (Select 17293865)

1.

High-throughput oncogene mutation profiling in human cancer.

Thomas RK, Baker AC, Debiasi RM, Winckler W, Laframboise T, Lin WM, Wang M, Feng W, Zander T, MacConaill L, Lee JC, Nicoletti R, Hatton C, Goyette M, Girard L, Majmudar K, Ziaugra L, Wong KK, Gabriel S, Beroukhim R, Peyton M, Barretina J, Dutt A, Emery C, Greulich H, Shah K, Sasaki H, Gazdar A, Minna J, Armstrong SA, Mellinghoff IK, Hodi FS, Dranoff G, Mischel PS, Cloughesy TF, Nelson SF, Liau LM, Mertz K, Rubin MA, Moch H, Loda M, Catalona W, Fletcher J, Signoretti S, Kaye F, Anderson KC, Demetri GD, Dummer R, Wagner S, Herlyn M, Sellers WR, Meyerson M, Garraway LA.

Nat Genet. 2007 Mar;39(3):347-51. Epub 2007 Feb 11. Erratum in: Nat Genet. 2007 Apr;39(4):567. Macconnaill, Laura E [corrected to MacConaill, Laura].

PMID:
17293865
2.

Identification of cancer genes by mutational profiling of tumor genomes.

Benvenuti S, Arena S, Bardelli A.

FEBS Lett. 2005 Mar 21;579(8):1884-90. Review.

3.

A DNA transposon-based approach to validate oncogenic mutations in the mouse.

Su Q, Prosser HM, Campos LS, Ortiz M, Nakamura T, Warren M, Dupuy AJ, Jenkins NA, Copeland NG, Bradley A, Liu P.

Proc Natl Acad Sci U S A. 2008 Dec 16;105(50):19904-9. doi: 10.1073/pnas.0807785105. Epub 2008 Dec 8.

4.

High-throughput genotyping in osteosarcoma identifies multiple mutations in phosphoinositide-3-kinase and other oncogenes.

Choy E, Hornicek F, MacConaill L, Harmon D, Tariq Z, Garraway L, Duan Z.

Cancer. 2012 Jun 1;118(11):2905-14. doi: 10.1002/cncr.26617. Epub 2011 Oct 17.

5.

Rapid targeted mutational analysis of human tumours: a clinical platform to guide personalized cancer medicine.

Dias-Santagata D, Akhavanfard S, David SS, Vernovsky K, Kuhlmann G, Boisvert SL, Stubbs H, McDermott U, Settleman J, Kwak EL, Clark JW, Isakoff SJ, Sequist LV, Engelman JA, Lynch TJ, Haber DA, Louis DN, Ellisen LW, Borger DR, Iafrate AJ.

EMBO Mol Med. 2010 May;2(5):146-58. doi: 10.1002/emmm.201000070.

6.

Mutational analysis of gene families in human cancer.

Bardelli A, Velculescu VE.

Curr Opin Genet Dev. 2005 Feb;15(1):5-12. Review.

PMID:
15661527
7.

COLD-PCR: a new platform for highly improved mutation detection in cancer and genetic testing.

Li J, Makrigiorgos GM.

Biochem Soc Trans. 2009 Apr;37(Pt 2):427-32. doi: 10.1042/BST0370427. Review.

PMID:
19290875
8.

Prospects for applying genotypic selection of somatic oncomutation to chemical risk assessment.

McKinzie PB, Delongchamp RR, Heflich RH, Parsons BL.

Mutat Res. 2001 Oct;489(1):47-78. Review.

PMID:
11673089
9.

Profiling critical cancer gene mutations in clinical tumor samples.

MacConaill LE, Campbell CD, Kehoe SM, Bass AJ, Hatton C, Niu L, Davis M, Yao K, Hanna M, Mondal C, Luongo L, Emery CM, Baker AC, Philips J, Goff DJ, Fiorentino M, Rubin MA, Polyak K, Chan J, Wang Y, Fletcher JA, Santagata S, Corso G, Roviello F, Shivdasani R, Kieran MW, Ligon KL, Stiles CD, Hahn WC, Meyerson ML, Garraway LA.

PLoS One. 2009 Nov 18;4(11):e7887. doi: 10.1371/journal.pone.0007887. Erratum in: PLoS One. 2010;5(9). doi: 10.1371/annotation/3a0c8fee-57ef-43ed-b6c2-55b503e6db5e. PLoS One. 2010;5(9). doi: 10.1371/annotation/613c7509-e4c9-42ac-82fb-fc504400d9e0.

10.

A polymorphism in HDM2 (SNP309) associates with early onset in superficial tumors, TP53 mutations, and poor outcome in invasive bladder cancer.

Sanchez-Carbayo M, Socci ND, Kirchoff T, Erill N, Offit K, Bochner BH, Cordon-Cardo C.

Clin Cancer Res. 2007 Jun 1;13(11):3215-20.

11.

Mutation-associated fusion cancer genes in solid tumors.

Kaye FJ.

Mol Cancer Ther. 2009 Jun;8(6):1399-408. doi: 10.1158/1535-7163.MCT-09-0135. Epub 2009 Jun 9. Review.

12.

Replacement of normal with mutant alleles in the genome of normal human cells unveils mutation-specific drug responses.

Di Nicolantonio F, Arena S, Gallicchio M, Zecchin D, Martini M, Flonta SE, Stella GM, Lamba S, Cancelliere C, Russo M, Geuna M, Appendino G, Fantozzi R, Medico E, Bardelli A.

Proc Natl Acad Sci U S A. 2008 Dec 30;105(52):20864-9. doi: 10.1073/pnas.0808757105. Epub 2008 Dec 23.

13.
14.

The genetics of childhood cancer.

Knudson AG.

Bull Cancer. 1988;75(1):135-8.

PMID:
3359055
15.

The application of microarray technology to the analysis of the cancer genome.

Cowell JK, Hawthorn L.

Curr Mol Med. 2007 Feb;7(1):103-20. Review.

PMID:
17311536
16.

Integrated genomic and pharmacological approaches to identify synthetic lethal genes as cancer therapeutic targets.

Mizuarai S, Irie H, Schmatz DM, Kotani H.

Curr Mol Med. 2008 Dec;8(8):774-83. Review.

PMID:
19075675
17.

High mutability of the tumor suppressor genes RASSF1 and RBSP3 (CTDSPL) in cancer.

Kashuba VI, Pavlova TV, Grigorieva EV, Kutsenko A, Yenamandra SP, Li J, Wang F, Protopopov AI, Zabarovska VI, Senchenko V, Haraldson K, Eshchenko T, Kobliakova J, Vorontsova O, Kuzmin I, Braga E, Blinov VM, Kisselev LL, Zeng YX, Ernberg I, Lerman MI, Klein G, Zabarovsky ER.

PLoS One. 2009 May 29;4(5):e5231. doi: 10.1371/journal.pone.0005231.

18.

Methods for detection of subtle mutations in cancer genomes.

Dahl C, Ralfkiaer U, Guldberg P.

Crit Rev Oncog. 2006 Jul;12(1-2):41-74. Review.

PMID:
17078206
19.

Genomic profiling of breast cancer.

Pandey A, Singh AK, Maurya SK, Rai R, Tewari M, Kumar M, Shukla HS.

J Surg Oncol. 2009 May 1;99(6):386-92. doi: 10.1002/jso.21249.

PMID:
19235775
20.

Alport syndrome. Molecular genetic aspects.

Hertz JM.

Dan Med Bull. 2009 Aug;56(3):105-52.

PMID:
19728970
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk